JP Morgan Maintains Overweight on Anterix, Lowers Price Target to $130
JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and lowers the price target from $133 to $130.
Read original at benzingaStocks · News reference
Anterix Q1 EPS $0.01 Beats $(0.21) Estimate, Sales $1.958M Miss $1.977M Estimate
Anterix (NASDAQ:ATEX) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.21) by 104.76 percent. This is a 102.08 percent increase over losses of $(0.48) per share from the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 8:08 PM
- Checked
- Aug 11, 2026, 8:08 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Anterix Backs SpaceX FCC Ex Parte Letter On Low Band Spectrum Buildout, Supporting SpaceX Proposal To Allow Technology‑Neutral Options For 896‑901/935‑940 MHz Broadband Licenses
Anterix (NASDAQ:ATEX) issued the following statement from Christopher Guttman-McCabe, Chief Regulatory and Corporate Communications Officer, in response to the recently filed ex parte letter to the FCC from
Read original at benzinga8-K filing — Anterix Inc. (ATEX)
Filed: 2026-08-06 AccNo: 0001304492-26-000041 Size: 203 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Read original at edgar